BFC Planning’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
Other funds holding IHE
BFC Planning's IHE Position: Q3 2026 in Review
BFC Planning increased its iShares US Pharmaceuticals ETF (IHE) stake by 24% in Q3 2026, buying an estimated $56.4K and bringing the position to 2,881 shares worth $290K. The position accounts for 0.01% of the portfolio, ranked #800.
BFC Planning first reported a position in IHE in Q3 2024 and has held it in 6 quarters since. 211 funds tracked by Wall St. Rank hold IHE as of Q3 2026.
- BFC Planning held 2,881 shares of iShares US Pharmaceuticals ETF worth $290K as of Q3 2026.
- BFC Planning bought 550 iShares US Pharmaceuticals ETF shares in Q3 2026, an estimated $56.4K.
- iShares US Pharmaceuticals ETF made up 0.01% of BFC Planning's portfolio in Q3 2026, its #800 holding.
- BFC Planning first reported a position in iShares US Pharmaceuticals ETF in Q3 2024 and has held it in 6 quarters since.
- 211 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.